URGENT UPDATE: New research reveals that obstructive sleep apnoea is costing the UK and US economies a staggering £137 billion annually. This alarming figure highlights an urgent health crisis that affects millions yet remains largely undiagnosed.
The study, conducted by researchers at University College London, surveyed over 4,000 adults across the UK and US. It found that approximately 20% of respondents reported experiencing breathing pauses during sleep on three or more nights, along with excessive daytime sleepiness—key indicators of sleep apnoea. This serious health condition, which affects an estimated 1 billion people globally, including 8 million in the UK, leads to loud snoring and can result in waking up gasping for breath.
The economic impact of untreated sleep apnoea is profound. The analysis estimates that the US incurs losses of $180 billion (£133 billion) each year, while the UK faces losses of £4.2 billion. Researchers caution that these figures likely underestimate the true costs, as they do not account for increased medical expenses or the financial repercussions of road traffic and workplace accidents.
The findings are published in the latest issue of the journal Thorax, emphasizing the need for immediate action. The authors advocate for workplace screening and early intervention, stating,
“Given the significant yet often overlooked burden of obstructive sleep apnoea and its economic impact, we urge policymakers to allocate resources towards developing an effective screening strategy and implementing targeted public health campaigns and policies.”
They stress that early detection and treatment could save billions in productivity costs.
However, despite advances in low-cost screening technologies, maintaining treatment poses challenges. Nearly two-thirds of patients discontinue the standard continuous positive airway pressure (CPAP) therapy. Other alternatives, such as weight loss drugs and mouth guards, may not be suitable for all individuals.
Concerns about job security also hinder diagnosis and treatment. Adrian Jones, national officer at the trade union Unite, emphasizes the need for protective measures for professional drivers, many of whom conceal sleep apnoea symptoms for fear of job loss. Jones stated,
“Professional drivers often hide issues of sleep apnoea out of fear of losing their jobs. Before introducing screening, employers must be fully educated that sleep apnoea can be effectively managed.”
He insists that workers must feel secure in reporting health issues without the risk of dismissal.
As this urgent situation unfolds, it is clear that the costs of obstructive sleep apnoea extend far beyond health, impacting workplace productivity and safety. Policymakers are urged to take action now, as millions remain undiagnosed and untreated, risking both their health and the economy.
Stay tuned for further updates on this developing story as more information becomes available.
